Improved ATAC-seq method and kit
The improved ATAC-seq method addresses the limitations of conventional methods by using a transposome with specific base sequences for targeted amplification and sequencing, enhancing the accuracy and efficiency of chromatin accessibility analysis with reduced sequencing depth and bias.
Patent Information
- Application Number
- PCT/JP2024/018258
- Authority / Receiving Office
- WO · WO
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2023-05-22
- Filing Date
- 2024-05-17
- Publication Date
- 2024-11-28
AI Technical Summary
Conventional ATAC-seq methods require high sequencing depth and are costly, with limited accuracy due to amplification bias and limited reads mapped to target regions, making it difficult to accurately quantify and analyze chromatin accessibility.
The improved ATAC-seq method involves using a transposome with a transposase binding sequence and a desired base sequence that includes an amplification base sequence and an identification sequence, allowing for targeted amplification and sequencing of tagment DNA from specific regions, reducing sequencing depth and eliminating amplification bias through unique molecular identifiers.
This approach enables accurate evaluation of chromatin accessibility with lower sequencing requirements, increased accuracy, and reduced bias, significantly improving the analysis of chromatin accessibility by focusing on specific target regions and eliminating amplification bias.
Smart Images

Figure JPOXMLDOC01-APPB-T000001 
Figure JPOXMLDOC01-APPB-T000002 
Figure JPOXMLDOC01-APPB-T000003
Abstract
Description
Improved ATAC-seq method and kit
[0001] The present invention relates to an improved assay for transposase-accessible chromatography with sequencing (ATAC-seq) method and kit. This application claims priority to Japanese Patent Application No. 2023-084002, filed May 22, 2023, the contents of which are incorporated herein by reference.
[0002] ATAC-seq analysis is a technique used to evaluate the chromatin accessibility of the entire genomic DNA. Figures 1 and 2 are schematic diagrams illustrating an example of conventional ATAC-seq analysis.
[0003] As shown in Figure 1, when transposomes are brought into contact with chromatin, the transposomes fragment (tagment) open chromatin regions, and adapter sequences are added to the ends of the fragments, resulting in a population of tagmented DNA.
[0004] As shown in Figure 2, an adapter sequence is added to the end of tagment DNA (tDNA). The tagment DNA is then amplified using primers specific to this adapter sequence and comprehensively sequenced using a next-generation sequencer.
[0005] For example, by mapping the obtained reads to a reference genome, the chromatin accessibility of the target region on the genomic DNA can be evaluated. That is, the region to which the reads are mapped can be determined to be an open chromatin region. Alternatively, by analyzing specific single nucleotide polymorphisms (SNPs) contained in the obtained reads, the effect of the SNPs on chromatin accessibility can be analyzed.
[0006] Conventional ATAC-seq analysis involves amplifying and sequencing tagment DNA throughout the genomic DNA, which requires a large sequencing depth and is costly. Furthermore, the number of reads mapped to the target region on the genomic DNA is limited, which can limit the analytical accuracy. Furthermore, biases during tagment DNA amplification can make it difficult to accurately quantify tagment DNA.
[0007] For example, Non-Patent Document 1 describes a method for accurately quantifying tagment DNA by using a unique molecular identifier in ATAC-seq analysis.
[0008] Zhu T., et al., ATAC-seq with unique molecular identifiers improves quantification and footprinting, COMMUNICATIONS BIOLOGY, 3: 675, 2020.
[0009] However, the method described in Non-Patent Document 1, like conventional ATAC-seq analysis, amplifies and sequences tagment DNA throughout the genomic DNA, requiring a large sequencing depth and high costs. Furthermore, the number of reads mapped to the target region on the genomic DNA is limited, which can limit the analytical accuracy. Therefore, the present invention aims to provide an improved ATAC-seq method and kit.
[0010] The present invention includes the following aspects: [1] Assay for transposase-accessible chromatin with a transposase-accessible chromatin, comprising: step (a) of contacting a transposome with chromatin and fragmenting an open chromatin region of the chromatin to obtain a population of tagment DNA, wherein the transposome is a complex formed by binding a DNA fragment having a transposase binding sequence and a desired base sequence to a transposase, and the tagment DNA has the desired base sequence at its end; step (b) of amplifying the population of tagment DNA to obtain an amplification product, and comprehensively sequencing the base sequences of the amplification product to obtain a population of reads; and step (c) of analyzing the population of reads.
[0013] [2] The ATAC-seq method according to [1], wherein the desired base sequence comprises an amplification base sequence and a discrimination sequence in this order from 5' to 3', and the tagment DNA population is amplified using a primer specific to a target region on genomic DNA and a primer specific to the amplification base sequence, and the identity of the discrimination sequences in the reads indicates that the reads are derived from one molecule of tagment DNA. [2] The ATAC-seq method according to [1], wherein the discrimination sequence is a random sequence of 10 to 25 bases. [3] The ATAC-seq method according to [1] or [2], wherein the desired base sequence further comprises a barcode sequence for sample multiplexing on the 3' side of the amplification base sequence. [4] The number of reads obtained in step (b) is 1 x 10 per sample. 4 ~1 x 10 5[5] A kit for carrying out the ATAC-seq method according to any one of [1] to [3], which comprises a transposome and a primer specific to a target region on genomic DNA, wherein the transposome is a complex formed by binding a DNA fragment having a transposase binding sequence and a desired base sequence to a transposase, and the desired base sequence comprises, in the 5' to 3' direction, an amplification base sequence and an identification sequence, in this order. [6] The kit according to [5], wherein the identification sequence is a random sequence of 10 to 25 bases. [7] The kit according to [5] or [6], wherein the desired base sequence further comprises a barcode sequence for sample multiplexing on the 3' side of the amplification base sequence.
[0011] According to the present invention, an improved ATAC-seq method and kit can be provided that can accurately evaluate chromatin accessibility in a target region.
[0012] FIG. 1 is a schematic diagram illustrating an example of conventional ATAC-seq analysis. FIG. 2 is a schematic diagram illustrating an example of conventional ATAC-seq analysis. FIG. 3 is a schematic diagram illustrating an example of improved ATAC-seq analysis. FIG. 4 is a schematic diagram illustrating one aspect of tagment DNA amplification. FIG. 5 is a schematic diagram illustrating one aspect of tagment DNA amplification. FIG. 6 is a schematic diagram illustrating one aspect of tagment DNA amplification. FIG. 7 is a graph showing the results of Experimental Example 1. FIG. 8 is a graph showing the results of Experimental Example 1. FIG. 9 is a graph showing the results of Experimental Example 2. FIG. 10 is a graph showing the results of Experimental Example 3.
[0013] [Improved ATAC-seq method] In one embodiment, the present invention provides a method for producing a tagment DNA population by: (a) contacting a transposome with chromatin and fragmenting open chromatin regions of the chromatin, wherein the transposome is a complex formed by binding a transposase to a DNA fragment having a transposase binding sequence and a desired base sequence, and the tagment DNA has the desired base sequence at its end; and (b) amplifying the tagment DNA population to obtain amplification products and comprehensively sequencing the base sequences of the amplification products. and (c) analyzing the population of reads. The ATAC-seq method includes the steps of: (a) obtaining a population of reads by sequencing; and (b) analyzing the population of reads; wherein the desired base sequence comprises, in the 5' to 3' direction, an amplification base sequence and a discrimination sequence, in this order; the population of tagment DNA is amplified using a primer specific to a target region on genomic DNA and a primer specific to the amplification base sequence; and the identity of the discrimination sequences in the reads indicates that the reads are derived from one molecule of tagment DNA.
[0014] The ATAC-seq method of this embodiment allows for evaluation of chromatin accessibility of a target region at a lower sequencing depth than conventional methods. Furthermore, the ATAC-seq method of this embodiment eliminates bias during tagment DNA amplification and allows for accurate quantification of tagment DNA.
[0015] 3 is a schematic diagram illustrating an example of the ATAC-seq method of this embodiment. In step (a), transposomes are brought into contact with chromatin to fragment open chromatin regions of the chromatin, thereby obtaining a population of tagmented DNA.
[0016] Here, a transposome is a complex formed by binding a transposase to a DNA fragment having a transposase binding sequence and a desired base sequence. The desired base sequence contains, in the 5' to 3' direction, an amplification base sequence and a recognition sequence. In Figure 3, "UMI" indicates the recognition sequence, and "ME" stands for mosaic end and indicates the transposase binding sequence.
[0017] The base sequence for amplification is used to amplify tagment DNA. As the base sequence for amplification, for example, any sequence of 14 to 25 bases can be used.
[0018] The identification sequence is used to identify tagment DNA at the molecular level. For example, a random sequence of 10 to 25 bases can be used as the identification sequence. Here, the random sequence is a sequence in which adenine residues, thymine residues, guanine residues, and cytosine residues are linked in random order. The length of the identification sequence may be any length that allows tagment DNA to be identified at the molecular level, and may be set appropriately depending on the number of cells to be analyzed, the expected level of chromatin accessibility in the target region, etc.
[0019] When such an identification sequence is used, tagment DNA derived from a target region on the genome will have a different identification sequence for each molecule, meaning that tagment DNA can be identified at the molecular level.
[0020] Any transposase commonly used in ATAC-seq analysis can be used without any particular limitation, including highly active modified Tn5 transposase.
[0021] As shown in Figure 3, the desired base sequence is added to the end of the tagment DNA obtained in step (a) by the activity of the transposase.
[0022] Subsequently, in step (b), the tagment DNA population is amplified to obtain an amplified product, and the base sequences of the amplified product are comprehensively sequenced to obtain a population of reads. Gene amplification can be performed by a general PCR reaction.
[0023] In the ATAC-seq method of this embodiment, specific amplification of a population of tagment DNA is performed using a primer specific to a target region on genomic DNA and a primer specific to an amplification base sequence added to the tagment DNA. The target region on genomic DNA refers to the region to be analyzed.
[0024] As shown in Figure 2, the conventional ATAC-seq method amplifies and sequences the entire tagment DNA of the genome by using primers specific to the adapter sequences attached to both ends of the tagment DNA. This requires a large sequencing depth and is costly. Furthermore, the number of reads that can be mapped to the target region on the genome DNA is limited, which can limit the analytical accuracy.
[0025] In contrast, the ATAC-seq method of this embodiment uses a primer specific to the target region on the genomic DNA and a primer specific to the amplification base sequence added to the tagment DNA to amplify only the tagment DNA derived from the target region on the genomic DNA. This allows for a much smaller sequencing depth than conventional methods.
[0026] One embodiment of tagment DNA amplification will now be described with reference to Figures 4 to 6. The tagment DNA population is preferably amplified by multiple PCR reactions. Furthermore, it is preferable to extract amplification products containing the target region using biotin-streptavidin binding or the like.
[0027] 4 is a schematic diagram illustrating the amplification step 1. First, in the amplification step 1, a linear amplification reaction is carried out using only a target region-specific primer biotinylated at the 5' end.
[0028] 5 is a schematic diagram illustrating amplification step 2. After amplification step 1 is performed, streptavidin beads are used to perform pull-down utilizing the biotin-streptoavidin binding reaction, and biotin-bound DNA fragments are recovered. Subsequently, amplification step 2 is performed using the recovered biotin-bound DNA fragments as a template. In amplification step 2, PCR is performed using a target region-specific primer designed closer to the desired base sequence than the target region-specific primer used in amplification step 1, and a primer specific to the base sequence for amplification added to the tagment DNA.
[0029] 6 is a schematic diagram illustrating the amplification step 3. In the amplification step 3, PCR is performed using the DNA fragment amplified in the amplification step 2 as a template to add an adapter sequence required for sequencing using a next-generation sequencer.
[0030] In each PCR reaction of amplification steps 1 to 3, it is preferable to include a transposase binding sequence whose 3' end is phosphorylated as a blocking primer in the reaction solution. In addition, it is preferable to use a DNA polymerase having 5' to 3' exonuclease activity.
[0031] This prevents DNA fragments having a transposase binding sequence and a desired base sequence that have been shed from the transposome sequence, or DNA fragments that are insufficiently extended in each PCR cycle, from functioning as primers to initiate a PCR reaction and overwriting inappropriate identification sequences.
[0032] The inventors have found that in the ATAC-seq method of this embodiment, the identification sequence may be detected in excess, in numbers greater than expected, and that this can be prevented by using the above-mentioned blocking primer.
[0033] The conventional ATAC-seq method requires 5 × 10 per sample. 7 In contrast, in the ATAC-seq method of this embodiment, the number of reads obtained in step (b) is set to 1 × 10 per sample. 4 ~1 x 10 5 For example, when chromatin derived from 10,000 to 20,000 cells is used as input, the number of reads obtained in step (b) can be reduced to 1 × 10 per sample. 5 can be reduced to a certain extent.
[0034] In the ATAC-seq method of this embodiment, substantially all of the amplified tagment DNA is derived from the target region on the genomic DNA. Therefore, compared to conventional methods, the number of reads mapped to the target region can be significantly increased, and analytical accuracy can be significantly improved. Hereinafter, the ATAC-seq method of this embodiment may be referred to as the Target ATAC-seq method.
[0035] Table 1 below shows a comparison between the conventional ATAC-seq method and the ATAC-seq method of this embodiment (Target ATAC-seq method).
[0036]
[0037] Subsequently, in step (c), the group of reads obtained in step (b) is analyzed. Here, reads with the same identification sequence can be determined to be reads derived from one molecule of tagment DNA. This eliminates bias when amplifying tagment DNA, and allows accurate quantification of tagment DNA.
[0038] This will be explained with reference to Figures 2 and 3. In the example shown in Figures 2 and 3, a specific SNP contained in the obtained read is analyzed to analyze the effect of the SNP on chromatin accessibility. In Figures 2 and 3, "REF" indicates the wild-type allele of the SNP, and "ALT" indicates the mutant allele of the SNP.
[0039] Here, calculation of the mutant allele ratio will be described. As shown in Figure 2, in the conventional ATAC-seq method, the mutant allele ratio is calculated as the number of reads having a mutant allele relative to the total number of reads.
[0040] In the case of Figure 2, there are two reads with wild-type alleles, and four and eight reads with mutant alleles, for a total of 12 molecules. Therefore, the mutant allele ratio is calculated as 2 / (2 + 4 + 8) = 1 / 7. However, this method is affected by bias that occurs during amplification of tagment DNA.
[0041] In contrast, as shown in Figure 3, the ATAC-seq method of this embodiment calculates the mutant allele ratio based on the number of tagment DNA molecules. That is, the mutant allele ratio is calculated as the number of tagment DNA molecules having a mutant allele relative to the total number of tagment DNA molecules. In Figure 3, "UMI-1," "UMI-2," and "UMI-3" each represent a different identification sequence.
[0042] In the case of Figure 3, there are two reads having a wild-type allele, and these reads have the same identification sequence "UMI-1." Therefore, it can be determined that these reads originate from one molecule of tagment DNA. Furthermore, among the reads having a mutant allele, there are four reads having the identification sequence "UMI-2," and eight reads having the identification sequence "UMI-3." Therefore, it can be determined that these reads originate from two molecules of tagment DNA. Therefore, the mutant allele ratio is calculated as 1 / (1+1+1) = 1 / 3. This method can eliminate the influence of bias that occurs during amplification of tagment DNA.
[0043] As described above, a transposome is a complex formed by binding a transposase to a DNA fragment having a transposase binding sequence and a desired base sequence. The desired base sequence contains, in the 5' to 3' direction, an amplification sequence and a recognition sequence, in this order.
[0044] The desired base sequence may further include a barcode sequence for sample multiplexing on the 3' side of the amplification base sequence. When a barcode sequence is used, the DNA fragment to be bound to the transposase preferably includes the amplification base sequence, the identification sequence, the barcode sequence, and the transposase binding sequence in the 5' to 3' direction.
[0045] A specific example of the base sequence of a DNA fragment having a transposase binding sequence and a desired base sequence is 5'-CGACGCTCTTCCGATCT NNNNNNNNNNNNNNNNNCTCTCTAT AGATGTGTATAAGAGACAG-3' (SEQ ID NO: 1). In this example, the 1st to 14th bases from the 5' end of SEQ ID NO: 1 are the amplification sequence, the 18th to 34th bases are the identification sequence, the 35th to 42nd bases are the barcode sequence, and the 43rd to 61st bases are the transposase binding sequence.
[0046] Using a different barcode sequence for each sample, tagment DNA is prepared, and then these samples are mixed to multiplex the samples. As a result, multiple samples can be mixed and collected in a single container for amplification, purification, sequencing, etc. After sequencing, each sample can be separated and analyzed based on the barcode sequence contained in the read. The barcode sequence can be, for example, any sequence of 4 to 10 bases.
[0047] [Kit] In one embodiment, the present invention provides a kit comprising a transposome and a primer specific to a target region on genomic DNA, wherein the transposome is a complex formed by binding a transposase to a DNA fragment having a transposase binding sequence and a desired base sequence, and the desired base sequence comprises, in the 5' to 3' direction, an amplification base sequence and an identification sequence, in this order. The kit of this embodiment allows the above-described Target ATAC-seq method to be suitably carried out.
[0048] In the kit of this embodiment, the transposome, transposase, transposase binding sequence, desired base sequence, identification sequence, etc. are the same as those described above. The identification sequence may be a random sequence of 10 to 25 bases. Furthermore, the desired base sequence may further include a barcode sequence for sample multiplexing on the 3' side of the identification sequence.
[0049] The present invention will now be described in more detail with reference to examples, but the present invention is not limited to the following examples.
[0050] Experimental Example 1 Allele-specific analysis of rs58107865 using human T cells Allele-specific analysis of the single nucleotide polymorphism (SNP) represented by NCBI accession number rs58107865 was carried out using human T cells.
[0051] The variant allele ratio (ALT ratio) of rs58107865 in genomic DNA (gDNA) of T cells from heterozygous donors in which rs58107865 is G / C is 0.5.
[0052] In tagmented DNA, when the mutant allele ratio is >0.5, it can be said that the SNP has a positive effect on chromatin accessibility. Also, in tagmented DNA, when the mutant allele ratio = 0.5, it can be said that the SNP has no effect on chromatin accessibility. Also, in tagmented DNA, when the mutant allele ratio is <0.5, it can be said that the SNP has a negative effect on chromatin accessibility.
[0053] Conventional ATAC-seq analysis can only obtain 1-2 target alleles per 50,000 reads, making the exact mutant allele ratio unknown. However, based on the results of conventional ATAC-seq analysis, the mutant allele ratio of rs58107865 in tagment DNA was predicted to be >0.5.
[0054] In this experimental example, the mutant allele ratio of rs58107865 was measured by Target ATAC-seq analysis using T cells derived from heterozygous donors as samples. Target ATAC-seq analysis was performed using six types of transposomes, each carrying the barcode sequences of barcodes 1 to 6. The base sequences of barcodes 1 to 6 are shown in Table 2 below.
[0055]
[0056] For samples 1 to 6, 20,000 T cells each derived from a heterozygous donor in which rs58107865 is G / C were reacted with each of the six types of transposomes described above to obtain tagmented DNA.
[0057] Subsequently, the tagment DNA obtained from each sample was linearly amplified using rs58107865-1 Rv (amplification step 1). rs58107865-1 Rv is a primer specific to the target region on genomic DNA (the region containing rs58107865) designed near the target region on genomic DNA, and its 5' end was biotin-modified. The base sequence of rs58107865-1 Rv is shown in SEQ ID NO: 2.
[0058] Next, to remove primers or primer dimers, the PCR products were size-selected using magnetic beads to recover fragments of 150 bp or longer. The amplified products were then purified using streptavidin-conjugated magnetic particles. Hereinafter, this procedure may be referred to as pull-down.
[0059] Next, the purified amplification products were each subjected to PCR amplification using a primer specific to the amplification base sequence and rs58107865-2 Rv (amplification step 2). rrs58107865-2 Rv is a primer specific to the target region on genomic DNA (the region containing rs58107865) and is specific to a position closer to rs58107865 than rs58107865-1 Rv. The base sequence of rs58107865-2 Rv is shown in SEQ ID NO: 3. Next, fragments ranging in length from 150 bp to 1,000 bp were recovered from the PCR product using magnetic beads.
[0060] Subsequently, PCR amplification was carried out to add adapters and index sequences required for sequencing using a sequencer (Illumina) (amplification step 3), and index sequences for sequencing were added.
[0061] Subsequently, sequencing was performed using a sequencer (product name "Miseq System", Illumina) to obtain a population of reads.
[0062] Figure 7 is a graph showing the results of the sequencing, tallying the number of reads obtained for each barcode sequence. In Figure 5, B1 to B6 on the horizontal axis represent barcodes 1 to 6, respectively. As a result, reads with barcodes 1 to 6 were obtained for samples 1 to 6, respectively, confirming that barcodes 1 to 6 functioned correctly.
[0063] 8 is a graph showing the results of tallying the number of reads mapped to the rs58107865 region, reads mapped to regions other than the rs58107865 region, and reads mapped to mitochondrial genes for the reads obtained in samples 1 to 6. In FIG. 8, "Chr4" indicates the rs58107865 region, "Chr-others" indicates regions other than the rs58107865 region, and "ChrMT" indicates mitochondrial genes. As a result, it was confirmed that more than 90% of the reads were mapped to the rs58107865 region.
[0064] Furthermore, conventional ATAC-seq analysis could only obtain about 1 to 2 target allele reads per 50,000 valid reads. In contrast, Target ATAC-seq analysis could obtain about 45,000 target allele reads per 50,000 valid reads. Note that valid reads refer to reads after excluding reads that were not mapped to the genome.
[0065] Next, the mutant allele ratio of rs58107865 was calculated based on the reads obtained in samples 1 to 6. The mutant allele ratio was calculated based on the following formula (1) and formula (2).
[0066] Mutant allele ratio=ALT / (ALT+REF) (1) In formula (1), "ALT" indicates the number of reads derived from the mutant allele (rs58107865 is C), and "REF" indicates the number of reads derived from the wild-type allele (rs58107865 is G).
[0067] Mutant allele ratio = ALT UMI / (ALT UMI +REF UMI )…(2) In formula (2), “ALT UMI" indicates the number of types of discriminant sequences possessed by the read derived from the mutant allele (rs58107865 is C), and "REF UMI " indicates the number of types of discriminant sequences possessed by the read derived from the wild-type allele (rs58107865 is G).
[0068] The mutant allele ratios calculated by the above formula (1) are shown in Table 3 below. In Table 3, "REF" indicates the number of reads derived from the wild-type allele (rs58107865 is G), and "ALT" indicates the number of reads derived from the mutant allele (rs58107865 is C).
[0069]
[0070] The mutant allele ratios calculated by the above formula (2) are shown in Table 4 below. UMI " indicates the number of types of discriminant sequences possessed by the read derived from the wild-type allele (rs58107865 is G), and "ALT UMI " indicates the number of types of discrimination sequences possessed by the read derived from the mutant allele (rs58107865 is C). Identical discrimination sequences indicate that the read is derived from one molecule of tagment DNA.
[0071]
[0072] As a result, it was confirmed that the mutant allele ratio calculated by the above formula (1) differs from the mutant allele ratio calculated by the above formula (2). Formula (1) is affected by bias in PCR amplification, but formula (2) can eliminate this effect.
[0073] The results in Table 4 confirmed that the mutant allele ratio of rs58107865 was >0.5 in tagment DNA, as previously predicted.
[0074] [Experimental Example 2] (Study on whether multiple regions can be simultaneously amplified) <<Amplification of a single region>> Using public data, SNPs within open chromatin regions were selected, and primers shown in Table 5 below were designed within DNA regions located near (within 100 bp of) the SNPs and contained within the open chromatin regions. In Table 5 below, "BioON" indicates biotinylated.
[0075]
[0076] Tagmented DNA was obtained by reacting 20,000 LCL cells, a human lymphoblastoid cell line, with transposomes. In the transposomes, the DNA fragment bound to the transposase contained an amplification sequence, a recognition sequence, and a transposase binding sequence in the 5' to 3' direction, in that order.
[0077] The resulting tagment DNA was then linearly amplified using the outer primers shown in Table 5 (amplification step 1). To remove primers or primer dimers, the PCR product was size-selected using magnetic beads to recover fragments of 150 bp or longer. The amplified product was then purified using streptavidin-coupled magnetic particles.
[0078] Next, the purified amplification products were each subjected to PCR amplification using a primer specific to the amplification base sequence and the inner primer shown in Table 5 (amplification step 2).Fragments ranging from 150 bp to 1,000 bp in length were then recovered from the PCR products using magnetic beads.
[0079] Next, PCR amplification was performed to add adapters and index sequences required for sequencing using a sequencer (Illumina) (amplification step 3), and index sequences for sequencing were added to obtain a sequencing library. The resulting library was then sequenced using a sequencer (product name "Miseq System", Illumina).
[0080] The upper graph in Figure 9 shows the number of reads mapped to each region after mapping the obtained reads. As a result, many reads were mapped to the position of chr8:11482373, confirming that the target region was efficiently amplified.
[0081] <<Amplification of 11 regions>> Using public data, SNPs within open chromatin regions were selected, and primers shown in Table 6 below were designed within DNA regions located near (within 100 bp of) the SNPs and contained within the open chromatin regions. In Table 6 below, "BioON" indicates biotinylated.
[0082]
[0083] Tagmented DNA was obtained by reacting 20,000 Jurkat cells, a cell line derived from human leukemia T cells, with transposomes. In the transposomes, the DNA fragment bound to the transposase contained an amplification sequence, a recognition sequence, and a transposase binding sequence in the 5' to 3' direction, in that order.
[0084] The resulting tagment DNA was then linearly amplified using the outer primer mixture shown in Table 6 (amplification step 1). To remove primers or primer dimers, the PCR product was size-selected using magnetic beads to recover fragments of 150 bp or longer. The amplified product was then purified using streptavidin-conjugated magnetic particles.
[0085] Next, the purified amplification products were each subjected to PCR amplification using a mixture of primers specific to the amplification base sequence and the inner primers shown in Table 6 (amplification step 2).Fragments ranging from 150 bp to 1,000 bp in length were then recovered from the PCR products using magnetic beads.
[0086] Subsequently, PCR amplification was performed to add adapters and index sequences required for sequencing using a sequencer (Illumina) (amplification step 3), and index sequences for sequencing were added to obtain a library for sequencing.
[0087] Subsequently, the resulting library was sequenced using a sequencer (product name "Miseq System", Illumina).
[0088] The middle graph in Figure 9 shows the number of reads mapped to each region as a result of mapping the obtained reads. As a result, it was confirmed that the 11 target regions were efficiently amplified.
[0089] <<Amplification of 27 regions>> Using public data, SNPs within open chromatin regions were selected, and primers shown in Tables 7-1, 7-2, and 7-3 below were designed within DNA regions located near (within 100 bp of) the SNPs and contained within the open chromatin regions. In Tables 7-1 to 7-3 below, "BioON" indicates biotinylated.
[0090]
[0091]
[0092]
[0093] Twenty thousand human peripheral blood-derived T cells were treated with transposomes to obtain tagmented DNA. In the transposomes, the DNA fragment bound to the transposase contained an amplification sequence, a recognition sequence, and a transposase binding sequence in the 5' to 3' direction.
[0094] The resulting tagment DNA was then linearly amplified using a mixture of outer primers shown in Tables 7-1 to 7-3 (amplification step 1). To remove primers or primer dimers, the PCR product was size-selected using magnetic beads to recover fragments of 150 bp or longer. The amplified product was then purified using streptavidin-coupled magnetic particles.
[0095] Next, the purified amplification products were each subjected to PCR amplification using a mixture of primers specific to the amplification base sequence and the inner primers shown in Tables 7-1 to 7-3 (amplification step 2).Fragments ranging from 150 bp to 1,000 bp in length were then recovered from the PCR products using magnetic beads.
[0096] Subsequently, PCR amplification was performed to add adapters and index sequences required for sequencing using a sequencer (Illumina) (amplification step 3), and index sequences for sequencing were added to obtain a library for sequencing.
[0097] Subsequently, the resulting library was sequenced using a sequencer (product name "Novaseq System", Illumina).
[0098] The lower part of Figure 9 is a graph showing the number of reads mapped to each region as a result of mapping the obtained reads. As a result, it was confirmed that the 27 target regions were efficiently amplified.
[0099] Experimental Example 3 (Detection of the Number of Molecules in the Input Chromatin Region) Three samples were prepared by dispensing LCL cell lines at 2,000, 4,000, 6,000, 8,000, 10,000, and 20,000 cells each. Each sample was reacted with transposomes to obtain tagment DNA. In the transposomes, the DNA fragments bound to the transposase contained an amplification sequence, an identification sequence, a barcode sequence, and a transposase binding sequence, in this order from 5' to 3'. Three barcodes, barcodes 7 to 9, were used. The tagment DNA from the three samples was identified by their respective barcode sequences and then mixed to multiplex the samples. The base sequences of barcodes 7 to 9 are shown in Table 8 below.
[0100]
[0101] The resulting tagment DNA was then linearly amplified using the outer primers shown in Table 5 (amplification step 1). To remove primers or primer dimers, the PCR product was size-selected using magnetic beads to recover fragments of 150 bp or longer. The amplified product was then purified using streptavidin-coupled magnetic particles.
[0102] Next, the purified amplification products were each subjected to PCR amplification using a primer specific to the amplification base sequence and the inner primer shown in Table 5 (amplification step 2).Fragments ranging from 150 bp to 1,000 bp in length were then recovered from the PCR products using magnetic beads.
[0103] Next, PCR amplification was performed to add adapters and index sequences required for sequencing using a sequencer (Illumina) (amplification step 3), and index sequences for sequencing were added to obtain a sequencing library. The resulting library was then sequenced using a sequencer (product name "Miseq System", Illumina).
[0104] From the obtained reads, only the reads that were mapped to the target region were extracted, and the overlap bias of PCR was eliminated using the identification sequence, and the number of molecules from which the reads originated was counted.
[0105] The results are shown in Figure 10. In Figure 10, the horizontal axis indicates the number of input cells, and the vertical axis indicates the number of tagment DNA molecules (number of molecules in the chromatin region) from which the obtained reads are derived.
[0106] As a result, it was confirmed that the number of molecules in the chromatin region of interest increased proportionally with the number of cells input, demonstrating that the method of this experimental example can accurately detect the number of molecules in the input chromatin region.
[0107] According to the present invention, an improved ATAC-seq method and kit can be provided.
Claims
1. An Assay for transposase-accessible chromatin with sequencing (ATAC-seq) method comprising: a step (a) of contacting a transposome with chromatin to fragment an open chromatin region of the chromatin to obtain a population of tagment DNA, wherein the transposome is a complex formed by binding a DNA fragment having a transposase binding sequence and a desired base sequence to a transposase, and the tagment DNA has the desired base sequence at an end; a step (b) of amplifying the population of tagment DNA to obtain an amplification product, and comprehensively sequencing the base sequences of the amplification products to obtain a population of reads; and a step (c) of analyzing the population of reads, wherein the desired base sequence comprises, in the 5' to 3' direction, an amplification base sequence and an identification sequence, in this order, The ATAC-seq method amplifies the population of tagment DNA using a primer specific to a target region on genomic DNA and a primer specific to the base sequence for amplification, and the same identification sequence in the reads indicates that the reads are derived from one molecule of tagment DNA.
2. The ATAC-seq method according to claim 1, wherein the identification sequence is a random sequence of 10 to 25 bases.
3. The ATAC-seq method according to claim 1 or 2, wherein the desired base sequence further comprises a barcode sequence for sample multiplexing on the 3' side of the amplification base sequence.
4. The number of reads obtained in the step (b) is 1 x 10 per sample. 4 ~1×10 5 The ATAC-seq method according to claim 1 or 2, 5. A kit for carrying out the ATAC-seq method described in claim 1, comprising a transposome and a primer specific to a target region on genomic DNA, wherein the transposome is a complex formed by binding a transposase to a DNA fragment having a transposase binding sequence and a desired base sequence, and the desired base sequence comprises, in the 5' to 3' direction, an amplification base sequence and an identification sequence, in this order.
6. The kit according to claim 5, wherein the identification sequence is a random sequence of 10 to 25 bases.
7. The kit of claim 5 or 6, wherein the desired base sequence further comprises a barcode sequence for sample multiplexing on the 3' side of the amplification base sequence.
Citation Information
Patent Citations
Systems and methods for multiplexed measurements in single and ensemble cells
WO2019152108A1
